BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14657947)

  • 21. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma.
    Linnoila RI; Sahu A; Miki M; Ball DW; DeMayo FJ
    Exp Lung Res; 2000 Dec; 26(8):595-615. PubMed ID: 11195458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung.
    Araki K; Ishii G; Yokose T; Nagai K; Funai K; Kodama K; Nishiwaki Y; Ochiai A
    Lung Cancer; 2003 May; 40(2):173-80. PubMed ID: 12711118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
    Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
    Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epithelium.
    Wang XY; Dakir el H; Naizhen X; Jensen-Taubman SM; DeMayo FJ; Linnoila RI
    Lab Invest; 2007 Jun; 87(6):527-39. PubMed ID: 17507989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.
    Schmid K; Angerstein N; Geleff S; Gschwendtner A
    Mod Pathol; 2006 Mar; 19(3):453-9. PubMed ID: 16462732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
    Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
    Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.
    Westerman BA; Breuer RH; Poutsma A; Chhatta A; Noorduyn LA; Koolen MG; Postmus PE; Blankenstein MA; Oudejans CB
    Int J Biol Markers; 2007; 22(2):114-23. PubMed ID: 17549667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
    Osada H; Tomida S; Yatabe Y; Tatematsu Y; Takeuchi T; Murakami H; Kondo Y; Sekido Y; Takahashi T
    Cancer Res; 2008 Mar; 68(6):1647-55. PubMed ID: 18339843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
    La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
    Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation.
    Rothrock AT; Stewart J; Li F; Racila E; Amin K
    Diagn Cytopathol; 2022 May; 50(5):230-234. PubMed ID: 35147301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors.
    Katsetos CD; Kontogeorgos G; Geddes JF; Herman MM; Tsimara-Papastamatiou H; Yu Y; Sakkas LI; Tsokos M; Patchefsky AS; Ehya H; Cooper HS; Provencio J; Spano AJ; Frankfurter A
    Arch Pathol Lab Med; 2000 Apr; 124(4):535-44. PubMed ID: 10747310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch signaling induces rapid degradation of achaete-scute homolog 1.
    Sriuranpong V; Borges MW; Strock CL; Nakakura EK; Watkins DN; Blaumueller CM; Nelkin BD; Ball DW
    Mol Cell Biol; 2002 May; 22(9):3129-39. PubMed ID: 11940670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
    Shilo K; Dracheva T; Mani H; Fukuoka J; Sesterhenn IA; Chu WS; Shih JH; Jen J; Travis WD; Franks TJ
    Arch Pathol Lab Med; 2007 Oct; 131(10):1555-60. PubMed ID: 17922592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.